🇺🇸 FDA
Pipeline program

Guselkumab

CR109179

Phase 2 mab active

Quick answer

Guselkumab for Colitis, Ulcerative is a Phase 2 program (mab) at Janssen Cilag International NV with 1 ClinicalTrials.gov record(s).

Program details

Company
Janssen Cilag International NV
Indication
Colitis, Ulcerative
Phase
Phase 2
Modality
mab
Status
active

Clinical trials